Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Sort By: Relevancy | Date | Type
Displaying items 13-24 of 26
» View wsbtradio.com items only
    Apr 15, 2013 |Story| Los Angeles Times
  1. Supreme Court considers gene patents; scientists react

    As the U.S. Supreme Court heard oral arguments in the case against Myriad Genetics, scientists who are skeptical of the idea of patenting genes said they were hopeful that the justices would overturn the Utah company's claims.
    As the U.S. Supreme Court heard oral arguments in the case against Myriad Genetics, scientists who are skeptical of the idea of patenting genes said they were hopeful that the justices would overturn the Utah company's claims. "I was on pins and needles...

    Tags: Patents, Copyrights and Trademarks, National Institutes of Health, Medical Specialization, Chemical Industry, Cardiologists

  2. Apr 15, 2013 |Story| Los Angeles Times
  3. Why genetic patents are good for patients [Blowback]

    <span class=&quot;toolSet" style="width: 335px;"><span class="byline">In their April 12 Op-Ed article "<a href="http://www.latimes.com/news/opinion/commentary/la-oe-darnovsky-breast-genes-patents-20130412,0,2847752.story">Who should own DNA? All of us</a>," Marcy Darnovsky and Karuna Jaggar write about Myriad's patents on BRCA1 and BRCA2, the so-called breast cancer genes (which were under review Monday at the U.S. Supreme Court), as if they have served little purpose in the development of tests that have helped more than 1 million women to understand their risks of breast cancer and ovarian cancer.</span></span>
    In their April 12 Op-Ed article "Who should own DNA? All of us," Marcy Darnovsky and Karuna Jaggar write about Myriad's patents on BRCA1 and BRCA2, the so-called breast cancer genes (which were under review Monday at the U.S. Supreme Court), as if they...

    Tags: Medical Procedures and Tests, Patents, Copyrights and Trademarks, Science and Technology, Medical Research, Chemical Industry

  4. Apr 15, 2013 |Story| Los Angeles Times
  5. The Supreme Court looks at gene patents, worries about biotech

    When the Supreme Court took up the question Monday of <a href=&quot;http://www.latimes.com/news/politics/la-pn-supreme-court-patents-human-genes-20130415,0,2991661.story">whether genes could be patented</a>, the justices were clearly concerned about preserving innovation in medicine and biotechnology. But the issue presented by Myriad Genetics' patents on the BRCA genes cuts both ways, leading to a potential split among the justices.
    When the Supreme Court took up the question Monday of whether genes could be patented, the justices were clearly concerned about preserving innovation in medicine and biotechnology. But the issue presented by Myriad Genetics' patents on the BRCA genes...

    Tags: Patents, Copyrights and Trademarks, Invention and Innovation, Chemical Industry, Entertainment Events, American Civil Liberties Union

  6. Apr 12, 2013 |Story| Los Angeles Times
  7. Who should own DNA? All of us

    Most court cases involving patent law are corporate battles, with one company suing another for infringing on its intellectual property rights and, therefore, profits. Big companies fighting over big money can seem painfully irrelevant, especially when so many of us are simply struggling to get by.
    Most court cases involving patent law are corporate battles, with one company suing another for infringing on its intellectual property rights and, therefore, profits. Big companies fighting over big money can seem painfully irrelevant, especially when so...

    Tags: Patents, Copyrights and Trademarks, Chemical Industry, Preventative Medicine, Polio, Breast Cancer

  8. Sep 25, 2012 |Story| Baltimore Sun
  9. ACLU asks Supreme Court to reconsider gene patenting case

    The American Civil Liberties Union has asked for a second time that the Supreme Court invalidate Myriad Genetics Inc.'s patents on two genes associated with hereditary breast and ovarian cancers, the latest salvo in a case with broad consequences for the future of gene-based medicine.
    The American Civil Liberties Union has asked for a second time that the Supreme Court invalidate Myriad Genetics Inc.'s patents on two genes associated with hereditary breast and ovarian cancers, the latest salvo in a case with broad consequences for...

    Tags: Patents, Copyrights and Trademarks, University of Utah, Laws, Blood, Washington, DC

  10. Sep 22, 2012 |Story| Baltimore Sun
  11. Gene patent case could impact patients, research

    Every time a woman is tested for gene mutations linked to significantly higher rates of breast and ovarian cancer, her blood is sent to a lab in Utah.
    Every time a woman is tested for gene mutations linked to significantly higher rates of breast and ovarian cancer, her blood is sent to a lab in Utah. That's because Salt Lake City-based Myriad Genetics Inc. owns the patents to the BRCA 1 and BRCA 2...

    Tags: Patents, Copyrights and Trademarks, DNA, Chemical Industry, Blood, University of Washington

  12. Mar 26, 2012 |Story| AP Broadcast
  13. Supreme Court: High Court Throws Out Human Gene Patents

    The Supreme Court on Monday threw out a lower court ruling allowing human genes to be patented, a topic of enormous interest to cancer researchers, patients and drug makers.
    Channel 2 News
    The Supreme Court on Monday threw out a lower court ruling allowing human genes to be patented, a topic of enormous interest to cancer researchers, patients and drug makers. The court overturned patents belonging to Myriad Genetics Inc. of Salt Lake City...

    Tags: Human Body, Patents, Copyrights and Trademarks, DNA, Medical Specialization, Chemical Industry

  14. Jul 29, 2011 |Story| Reuters
  15. Utah-based Myriad can patent breast cancer genes: court

    CHICAGO (Reuters) - A U.S. federal appeals court affirmed the right of Myriad Genetics to patent two genes linked to breast cancer, overturning a lower court ruling that threatened a key element of the biotech business.
    Reuters
    CHICAGO (Reuters) - A U.S. federal appeals court affirmed the right of Myriad Genetics to patent two genes linked to breast cancer, overturning a lower court ruling that threatened a key element of the biotech business. The U.S. Court of Appeals for...

    Tags: Human Body, Patents, Copyrights and Trademarks, DNA, Laws, Chemical Industry

  16. May 11, 2011 |Story| Daily American
  17. Gene patenting future at tisk

    Somerset
    A judge’s ruling in the court case ACLU v. Myriad could have a substantial impact on the future of gene patenting in the United States. In March 2010, Judge Robert Sweet ruled that Myriad Genetics did not have the right to patent the BRCA1 and BRCA2...

    Tags: Human Body, Patents, Copyrights and Trademarks, DNA, U.S. Department of Justice, Health

  18. Jan 11, 2010 | Los Angeles Times
  19. Genes are complex; gene patents might be more so

    Booster Shots
    Genetic research breakthroughs have come to be expected -- greeted with a sense of inevitability and the quiet assurance that science will ultimately puzzle out, then cure, human disease. But how those breakthroughs actually yield benefits is complicated....
  20. Aug 19, 2007 |Story| Chicago Tribune
  21. The week ahead

    Chicago Tribune
    Monday: --July leading economic indicators --Earnings: Lowe's Cos.; Perry Ellis International Inc. Tuesday: --Earnings: Adams Respiratory Therapeutics Inc.; American Eagle Outfitters Inc.; Analog Devices Inc.; BJ's Wholesale Club Inc.; Jack Henry &...

    Tags: Burger King Corp., Foot Locker Incorporated, JDS Uniphase Corporation, Target Brands, Inc., Gap Inc.

  22. Sep 11, 2002 |Story| Chicago Tribune
  23. To scientists, ID project is a sacred trust

    Tribune national correspondent
    For most of the last year, a white, two-story tent on a dreary side street near the East River has sheltered nearly 20,000 riddles. The 16 refrigerated trailers inside the tent have served as the temporary resting places for 19,906 bits of flesh and bone...

    Tags: National Security, DNA, Death, Crimes, Plastic Surgeons

< Previous1  2  3Next >
Original site for Myriad Genetics Incorporated topic gallery.
Loading...
 
 

Date:

Credit:

User-submitted

Tags:

Rate:
Sending...

E-mail this photo

Error: malformed email address(es)
Both "from" and "recipient" email fields are required.

Recipient E-mail Addresses

(up to 3, separated by commas) Send me a copy.

From:

e-mail | buy this photo | link to photo
Myriad Genetics Incorporated Photos
On Thursday, a federal appeals court found that Myriad...
(August 17, 2012)
dna helix
A woman gets a mammogram to screen for breast cancer. A...
(July 25, 2012)
Woman getting mammogram